Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.

Autor: Thiele, Elizabeth A.1 ethiele@mgh.harvard.edu, Marsh, Eric D.2, French, Jacqueline A.3, Mazurkiewicz-Beldzinska, Maria4, Benbadis, Selim R.5, Joshi, Charuta6, Lyons, Paul D.7, Taylor, Adam8, Roberts, Claire8, Sommerville, Kenneth9,10, GWPCARE4 Study Group (CORPORATE AUTHOR)
Zdroj: Lancet. 3/17/2018, Vol. 391 Issue 10125, p1085-1096. 10p.
Databáze: Academic Search Ultimate